Finance

Lists
EGRX:OTCMKTS
Eagle Pharmaceuticals Inc
USD 0,97
0,00%
(0,00) 1D
USD 0,60
-38,14% (-0,37)
Pre-market
Closed: 2 Okt., 09:59:55 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EGRX...
Mkt. cap
12,60 m
Avg. vol.
2,04 k
Volume
1,56 k
52-wk high
USD 1,80
52-wk low
USD 0,00
Beta
0,86
Shares outstanding
12,99 m
No. of employees
134
Mkt. cap
12,60 m
Avg. vol.
2,04 k
Volume
1,56 k
52-wk high
USD 1,80
52-wk low
USD 0,00
Beta
0,86
Shares outstanding
12,99 m
No. of employees
134
News stories
From web sources and news partners
About Eagle Pharmaceuticals Inc
CEOScott L. Tarriff
Employees134
Founded2007
HeadquartersWoodcliff Lake, New Jersey, Verenigde State van Amerika
Sector-
Websiteeagleus.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
Revenue
Cost of goods sold
Cost of revenue
Research and development expenses
Total research and development expenses
Selling, general, and admin expenses
Operating expense
Total operating expenses
Operating income
Other non operating income
EBT including unusual items
EBT excluding unusual items
Income tax expense
Effective tax rate
Other operating expenses
Net income
Net profit margin
Earnings per share
Interest and investment income
Interest expense
Net interest expenses
Depreciation and amortization charges
EBITDA
Gain or loss from assets sale
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme